If You Build it They Will Come
Accuron Technologies has invested 11.2 million to commercialize AWAK’s sorbent platform, which aims to reduce the cost and complexity of dialysis while making it smaller and more portable.
Read the full article » | Posted 12-09-2016
Related Articles
- VenoStent, Inc. is Recruiting Patients for a Clinical Trial of the SelfWrap Posted 10-14-2025
- Diality Treated its First Patient in the Moda-flx Home IDE PRESCRIBE Cinical Trial Posted 10-14-2025
- eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant Posted 09-15-2025
- The First Artificial Kidney Built in Canada has Ties to London: A Revolution in Care for Patients with Kidney Failure Posted 09-15-2025

